Replies to post #153490 on Biotech Values

[bladerunner1717]

PGS,

You may be absolutely right about GNVC, but your reasoning seems a bit muddle-headed.

You write:

it... happens to be a biotech company that has proven an inability to get even close to selling a drug.

Well, you could say that about ARIA, PCYC or MDVN. They all had drug failures. Companies can come back. GNVC may not be one of them, but not for the reasons that you cite.


Bladerunner